• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.

作者信息

Henriques-Normark Birgitta, Narciso Ana Rita

机构信息

Department of Microbiology, Tumor and Cell Biology.

Department of Clinical Microbiology Karolinska University Hospital Stockholm, Sweden.

出版信息

Am J Respir Crit Care Med. 2022 Dec 1;206(11):1312-1314. doi: 10.1164/rccm.202207-1342ED.

DOI:10.1164/rccm.202207-1342ED
PMID:35856830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9746867/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca50/9746867/5b26ec34b908/rccm.202207-1342EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca50/9746867/5b26ec34b908/rccm.202207-1342EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca50/9746867/5b26ec34b908/rccm.202207-1342EDf1.jpg

相似文献

1
An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.肺炎球菌3型的人体实验性定植模型有潜力用于疫苗研究。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1312-1314. doi: 10.1164/rccm.202207-1342ED.
2
Intranasal Immunization with the Commensal Confers Protective Immunity against Pneumococcal Lung Infection.鼻腔免疫共生菌可提供针对肺炎链球菌肺部感染的保护免疫。
Appl Environ Microbiol. 2019 Mar 6;85(6). doi: 10.1128/AEM.02235-18. Print 2019 Mar 15.
3
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).肺炎链球菌血清型 3 掩盖了 PCV13 介导的加拿大成人社区获得性肺炎住院患者群体免疫：加拿大免疫研究网络（CIRN）严重后果监测（SOS）网络的一项研究。
Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23.
4
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.与b型脑膜炎奈瑟菌外膜蛋白结合的七价肺炎球菌疫苗与婴儿肺炎链球菌的鼻咽部携带情况
Vaccine. 2003 Jun 2;21(19-20):2627-31. doi: 10.1016/s0264-410x(03)00039-2.
5
Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children.关于13价肺炎球菌结合疫苗对儿童3型肺炎链球菌感染影响的矛盾观察的评论
Vaccine. 2018 Sep 5;36(37):5495-5496. doi: 10.1016/j.vaccine.2018.07.069. Epub 2018 Aug 1.
6
Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?使用结合疫苗进行肺炎球菌免疫接种：10价疫苗和13价疫苗相似吗？
Future Microbiol. 2019 Jul;14:921-923. doi: 10.2217/fmb-2019-0151. Epub 2019 Aug 2.
7
Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.日本东海地区5年间肺炎球菌结合疫苗对儿童非侵袭性肺炎链球菌分离株血清型分布及药敏趋势的影响
J Infect Chemother. 2014 Jul;20(7):423-8. doi: 10.1016/j.jiac.2014.03.010. Epub 2014 May 5.
8
Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.19A 型肺炎链球菌分离株在结合疫苗问世前后的特征。1986 年至 2015 年单中心经验。
Vaccine. 2018 Aug 23;36(35):5245-5250. doi: 10.1016/j.vaccine.2018.07.055. Epub 2018 Jul 27.
9
Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil.10 价肺炎球菌结合疫苗对巴西儿童鼻咽部肺炎链球菌携带的长期影响。
Vaccine. 2019 Aug 23;37(36):5357-5363. doi: 10.1016/j.vaccine.2019.07.043. Epub 2019 Jul 24.
10
PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.基于聚合酶链反应（PCR）对新出现的肺炎链球菌22F和33F血清型的鉴别
J Microbiol Methods. 2018 Jan;144:99-106. doi: 10.1016/j.mimet.2017.11.017. Epub 2017 Nov 21.

本文引用的文献

1
Human Infection Challenge with Serotype 3 Pneumococcus.3型肺炎球菌的人体感染挑战
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1379-1392. doi: 10.1164/rccm.202112-2700OC.
2
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease.糖衣杀手：3型肺炎球菌疾病
Front Cell Infect Microbiol. 2020 Dec 23;10:613287. doi: 10.3389/fcimb.2020.613287. eCollection 2020.
3
A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large Fragment from an Oral Streptococcus.一种新型肺炎球菌荚膜类型 10D 是第 100 种血清型，具有来自口腔链球菌的大片段。
mBio. 2020 May 19;11(3):e00937-20. doi: 10.1128/mBio.00937-20.
4
Evolution of Serotype 3 in England and Wales: A Major Vaccine Evader.血清型 3 在英格兰和威尔士的演变：主要的疫苗逃避者。
Genes (Basel). 2019 Oct 25;10(11):845. doi: 10.3390/genes10110845.
5
Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.英格兰七种和十三种价肺炎球菌结合疫苗的有效性：2006-2018 年间接队列设计。
Vaccine. 2019 Jul 26;37(32):4491-4498. doi: 10.1016/j.vaccine.2019.06.071. Epub 2019 Jul 2.
6
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations.比较 10 价肺炎球菌结合疫苗与 13 价肺炎球菌结合疫苗对等效人群中侵袭性肺炎球菌病的影响。
Clin Infect Dis. 2017 Nov 13;65(11):1780-1789. doi: 10.1093/cid/cix685.
7
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.斯皮德网国家高价肺炎球菌结合疫苗对儿童侵袭性肺炎球菌病的影响：一项观察性多中心研究。
Lancet Respir Med. 2017 Aug;5(8):648-656. doi: 10.1016/S2213-2600(17)30110-8. Epub 2017 Mar 27.
8
Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes.尽管13价结合疫苗的其他血清型持续减少，但在葡萄牙，3型血清型仍是2012 - 2014年成人侵袭性肺炎球菌疾病的主要病因。
Front Microbiol. 2016 Oct 14;7:1616. doi: 10.3389/fmicb.2016.01616. eCollection 2016.
9
Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.在瑞典斯德哥尔摩引入疫苗8年后，由于低侵袭性非疫苗血清型的扩张，肺炎球菌携带率未发生改变。
Vaccine. 2016 Aug 31;34(38):4565-4571. doi: 10.1016/j.vaccine.2016.07.031. Epub 2016 Jul 26.
10
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.7价肺炎球菌结合疫苗和13价肺炎球菌结合疫苗对瑞典斯德哥尔摩侵袭性肺炎球菌疾病及携带情况的影响。
Eur Respir J. 2016 Apr;47(4):1208-18. doi: 10.1183/13993003.01451-2015. Epub 2016 Jan 21.